Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Inhibrx Biosciences, Inc
University of Oxford
Innovent Biologics (Suzhou) Co. Ltd.
Boston Scientific Corporation
Sun Yat-sen University
Russian Academy of Medical Sciences
Japan Clinical Oncology Group
Shanghai Chest Hospital